Cargando…

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

BACKGROUND: DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates in cell cycle progression through MAPK signalling pathway activation. Moreover, tumor-spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katzendorn, Olga, Peters, Inga, Dubrowinskaja, Natalia, Tezval, Hossein, Tabrizi, Pouriya Faraj, von Klot, Christoph A., Hennenlotter, Jörg, Lafos, Marcel, Kuczyk, Markus A., Serth, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061065/ https://www.ncbi.nlm.nih.gov/pubmed/33882870 http://dx.doi.org/10.1186/s12885-021-08172-1

Ejemplares similares

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
por: Katzendorn, Olga, et al.
Publicado: (2022)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes
por: Serth, Jürgen, et al.
Publicado: (2022)

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
por: Mazdak, Mehrdad, et al.
Publicado: (2021)

Spider silk erectile nerve reconstruction in robot-assisted radical prostatectomy: a first-in-men feasibility analysis
por: Harke, Nina N., et al.
Publicado: (2023)

TACSTD2 upregulation is an early reaction to lung infection
por: Lenárt, Sára, et al.
Publicado: (2022)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014)

Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020)

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
por: Tezval, Hossein, et al.
Publicado: (2009)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Genetic Suppressor Element 1 (GSE1) Promotes the Oncogenic and Recurrent Phenotypes of Castration-Resistant Prostate Cancer by Targeting Tumor-Associated Calcium Signal Transducer 2 (TACSTD2)
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy
por: Jongkhajornpong, Passara, et al.
Publicado: (2015)

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
por: Peters, Inga, et al.
Publicado: (2007)

The role of tacstd-2 level in hepatitis C patients (controlled clinical research)
por: Sahin, Memduh, et al.
Publicado: (2019)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Postnatal Growth and DNA Methylation Are Associated With Differential Gene Expression of the TACSTD2 Gene and Childhood Fat Mass
por: Groom, Alexandra, et al.
Publicado: (2012)

DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies
por: Peters, Inga, et al.
Publicado: (2014)

Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer
por: Abbas, Mahmoud, et al.
Publicado: (2023)

Identification and characterization of a novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy
por: Paliwal, Preeti, et al.
Publicado: (2010)

Novel Mutations in TACSTD2 Gene in Families with Gelatinous Drop-like Corneal Dystrophy (GDLD)
por: Alehabib, Elham, et al.
Publicado: (2017)

A novel TACSTD2 mutation identified in two Chinese brothers with gelatinous drop-like corneal dystrophy
por: Jing, Yang, et al.
Publicado: (2009)

Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis
por: Wang, F, et al.
Publicado: (2014)

Clinical and Ultrastructural Studies of Gelatinous Drop-Like Corneal Dystrophy (GDLD) of a Patient with TACSTD2 Gene Mutation
por: Masmali, Ali, et al.
Publicado: (2019)

Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma
por: Sekhar, Vandana, et al.
Publicado: (2018)

Two novel mutations of TACSTD2 found in three Japanese gelatinous drop-like corneal dystrophy families with their aberrant subcellular localization
por: Nakatsukasa, Mina, et al.
Publicado: (2011)

Gelatinous drop-like corneal dystrophy with a novel mutation of TACSTD2 manifested in combination with spheroidal degeneration in a Chinese patient
por: Zhang, Bei, et al.
Publicado: (2010)

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both
por: Tezval, Hossein, et al.
Publicado: (2021)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

A New in Vitro Model of GDLD by Knocking Out TACSTD2 and Its Paralogous Gene EpCAM in Human Corneal Epithelial Cells
por: Xu, Peng, et al.
Publicado: (2018)

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)

ShinyLUTS—A Shiny web application for structured data management and analysis for patients with lower urinary tract symptoms (LUTS)
por: von Klot, Christoph-Alexander Joachim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9fj7b7ii5764auu4pstplsf22